Kymera Therapeutics (KYMR) Stock
Kymera Therapeutics (KYMR) closed at $121.52 on Nov 17, 2026; its Tenet Score is 41 of 100 against 340 Healthcare peers.
23 figures withheld by our checks. Each blank figure names its reason.
Key stats
- Close
- $121.52
- Nov 17, 2026
- Market cap
- $10.7B
- share price × the latest quarter's diluted weighted-average share count (vendor)
- 52-week range
- 62.13 – 142.92
- low → high · as of close, Nov 16, 2026
- Tenet Score
- 41/100
- Weak · 340 Healthcare peers
Industry: Drugs
Kymera Therapeutics Inc scores 41/100. Weak. Strongest on financial health, growth is the soft spot versus 340 Healthcare peers.
Tenet Score · vs sector
n=340Factor grades
Price
The whole report, at a glance · every card is a live peek, click any to open the section
- ✕ Buffett Quality
- ✕ Piotroski F-Score
- ✕ Graham Defensive
- ✕ Quality Compounder
- ✓ Drawdown Context
- ~ Reversal Evidence
13F flows & insider trades land here.
Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in…
Similar-sized companies in Drugs
The 10 companies in this industry closest in market cap, as of Nov 16, 2026.
| Company | Tenet Score | Market cap |
|---|---|---|
| Elanco Animal Health IncELAN | 37 | $13.2B |
| Dr. Reddy's Laboratories Ltd.RDY | 45 | $12.3B |
| Bio-Techne CorpTECH | 51 | $11.4B |
| Biomarin Pharmaceutical Inc.BMRN | 43 | $11.2B |
| Halozyme Therapeutics Inc.HALO | 71 | $11.0B |
| Repligen Corp.RGEN | 49 | $10.4B |
| Madrigal Pharmaceuticals IncMDGL | 32 | $9.8B |
| TG Therapeutics IncTGTX | 43 | $9.6B |
| Spyre Therapeutics Inc.SYRE | 43 | $9.4B |
| Krystal Biotech IncKRYS | 66 | $8.8B |
Common questions
What sector and industry is Kymera Therapeutics in?
Kymera Therapeutics is in the Healthcare sector and the Drugs industry.
What is Kymera Therapeutics' Tenet Score?
Kymera Therapeutics' Tenet Score is 41 out of 100, ranked against 340 Healthcare peers as of Nov 16, 2026.




